Future-proof vial filling – How flexibility Along the Line Defines Success

Syntegon’s integrated vial filling systems deliver modular automation and efficiency, helping pharma adapt to rising demands and stricter regulations.

Protein Antibody Development: How To Choose The Best CDMO

Selecting the right CDMO ensures effective, high-caliber antibody development. Think about knowledge, openness, and agreement with the project's objectives.

CDMOs Must Reorganize to Maximize Revenue and Competitiveness

CDMOs must streamline their pricing strategies, improve their value-added services, and reorganize to optimize revenue in a fragmented and competitive market.

Pharmaceutical CMO Market is Set for a 7.29% CAGR by 2028

The pharmaceutical CMO market is projected to grow at a 7.29% CAGR by 2028, driven by growing demand for generics and biologics, coupled with analytics use.

Global CDMO Market for Cell and Gene Therapy Expands Rapidly

The cell and gene therapy CDMO market valued at $5.19B in 2022 and is expected to grow 17.5% CAGR by 2029, driven by better investment and innovative treatments.

CDMO Market for AAV Therapies to Hit $2.566 Billion By 2033

By 2033, the AAV CDMO market is projected to increase at a 24.61% CAGR, propelling revenue growth to $2.566 billion from gene therapy and R&D expenditures.